Danielle M. Nijkamp
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Danielle M. Nijkamp.
Transplantation | 2010
Michiel E. Erasmus; Erik Verschuuren; Danielle M. Nijkamp; J. Wytse Vermeyden; Wim van der Bij
Background. Despite the increasing use of extended lung donors, the shortage of lung donors remains. Usage of non-heart-beating (NHB) lung donors contributes to fight this shortage. We describe our experience in 21 consecutive adult lung transplantations using nonheparinized category III NHB donors and standard flush preservation. Methods. From January 2005 to December 2008, we collected donor and recipient data of all NHB category III lung transplantations performed in our center. For comparison, we also collected the data of all heart-beating (HB) lung transplantations in the same period. We focused on data describing the donor, the donor procedure, the recipients primary graft dysfunction, survival, rejection episodes, and the lung graft function. Results. Twenty-one NHB and 77 HB lung transplantations were performed. Circulation arrest occurred after 14 (4–62) min and warm ischemia time was 30 (19–44) min. Occurrence of primary graft dysfunction, acute rejection episodes, development of bronchiolitis obliterans syndrome was equal to the HB cohort as was the 2 years survival of 95% in the NHB group compared with 86% in the HB group. Lung graft function during the first 2 years tended to be better preserved in the NHB group. Conclusion. Category III NHB lung donation is a good alternative in addition to HB lung donation. Using nonheparinized category III NHB donors and standard ante- and retrograde, flush perfusion resulted in good lung graft function and survival. NHB donation offers a great opportunity to reduce the burden of donor lung shortage.
Liver Transplantation | 2006
Danielle M. Nijkamp; Maarten J. H. Slooff; Christian S. van der Hilst; Alexander J. C. IJtsma; Koert P. de Jong; Paul M. J. G. Peeters; Robert J. Porte
The exact frequency and clinical consequences of surgical hepatic injuries during organ procurement are unknown. We analyzed the incidence, risk factors, and clinical outcome of surgical injuries in 241 adult liver grafts. Hepatic injuries were categorized as parenchymal, vascular, or biliary. Outcome variables were bleeding complications, hepatic artery thrombosis (HAT), and graft survival. In 82 livers (34%), 96 injuries were detected. Most injuries were minor, but clinically relevant injuries were detected in 6.6% (16/241) of the livers. Fifty (21%) liver grafts had some degree of parenchymal or capsular injury, 40 (17%) had vascular injury, and 6 (2%) had an injury to the bile duct. Procurement region was the only risk factor significantly associated with surgical injury. The rate of hepatic artery injury was significantly higher in livers with aberrant arterial anatomy. Bleeding complications were found in 18% of patients who received livers with a parenchymal or capsular injury in contrast to 9% without parenchymal injury (P = 0.065). HAT was found in 23% of the patients who received a liver with arterial injury compared to 4% without arterial injury (P = 0.001). Overall graft survival rates were not significantly different for grafts with or without anatomical injury. In conclusion, surgical injuries of donor livers are an underestimated problem in liver transplantation and can be observed in about one‐third of all cases. Clinically relevant injuries are detected in 6.6% of all liver grafts. Arterial injuries are associated with an increased risk of HAT. Liver Transpl 12:1365‐1370, 2006.
Journal of Heart and Lung Transplantation | 2008
Danielle M. Nijkamp; Wim van der Bij; Erik Verschuuren; Martin B.A. Heemskerk; Erwin de Buijzer; Michiel E. Erasmus
Lungs from non-heart-beating (NHB) donors are seldom used in The Netherlands despite the good quality of these organs. Based on a retrospective analysis of 162 NHB donor procedures we found that only 5% of the lungs were actually utilized, but that 30% of the lungs were suitable for transplantation. Not recognizing the suitability of NHB lungs is likely the main reason for their non-availability.
Transplant International | 2011
Danielle M. Nijkamp; Richard Gerritsen; Jan Niesing; Marije Smit; Rutger J. Ploeg
Transplant International | 2011
Danielle M. Nijkamp; Rik T. Gerritsen; Jan Niesing; Marije Smit; Rutger J. Ploeg
Liver Transplantation | 2010
Alexander J. C. IJtsma; Christian S. van der Hilst; Danielle M. Nijkamp; Jan T. Bottema; Bart van Hoek; Geert Kazemier; Robert J. Porte; Maarten J. H. Slooff
Transplant International | 2009
Alexander J. C. IJtsma; Christian S. van der Hilst; Danielle M. Nijkamp; Jan T. Bottema; Bart van Hoek; Herold J. Metselaar; Robert J. Porte; Maarten J. H. Slooff
Transplant International | 2009
Alexander J. C. IJtsma; Christian S. van der Hilst; Danielle M. Nijkamp; Jan T. Bottema; Bart van Hoek; Herold J. Metselaar; Robert J. Porte; Maarten J. H. Slooff
Liver Transplantation | 2009
Alexander J. C. IJtsma; Christian S. van der Hilst; Danielle M. Nijkamp; Jan T. Bottema; Maarten J. H. Slooff
Transplant International | 2007
Danielle M. Nijkamp; Erik Verschuuren; Wim van der Bij; Martin B.A. Heemskerk; Erwin de Buijzer; Piet W. Boonstra; Michiel E. Erasmus